Ensysce Biosciences Inc ENSC

Alternate Symbol(s): ENSCW

Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company. The Company develops solutions for severe pain relief while reducing the potential for opioid misuse, abuse, and overdose. Its pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection (TAAP) platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant (MPAR) platform. Its lead product, PF614, is a TAAP extended-release oxycodone and a potential analgesic to treat severe pain. Its second product, PF614-MPAR, is to treat severe pain with the added benefit of oral overdose protection, is a combination product of the TAAP prodrug PF614 with a trypsin inhibitor. Additionally, nafamostat, which is an ingredient in its overdose protection combination products, is also being developed for the intended purpose of treating infection and pulmonary lung diseases.

NDAQ:ENSC - Post by User

Ensysce Biosciences Inc

<< Previous

Bullboard Posts

Next >>

(156)
•••

Post by Iseneschalon Apr 19, 2023 2:13pm

100 Views

Post# 35403487

ENSC...... Is that a lil gap down ?

Vols have dried up....share price is getting whack.... Mr. M is licking his chops and laughing all the way to the bank.

Now he's sayin..... Anymore weak hands?

<< Previous

Bullboard Posts

Next >>

Why Mining Majors Are Quietly Pouring Billions Into Small-Caps